April 03, 2025

Depemokimab Reduces Nasal Polyps, Obstruction in CRSwNP

Depemokimab significantly reduced nasal polyp scores and obstruction symptoms in patients with chronic rhinosinusitis in the ANCHOR-1 and ANCHOR-2 trials. The data support depemokimab as a twice-yearly treatment option, researchers reported.

Conexiant

April 03, 2025

New Option for IgA Nephropathy Management

The FDA has granted accelerated approval to Vanrafia (atrasentan) for reducing proteinuria in adults with primary immunoglobulin A nephropathy who are at risk of rapid disease progression.

Conexiant

April 03, 2025

Patterns in Adherence to USPSTF Lung Cancer Screening Guidelines

In a study reported as a research letter in JAMA Oncology, Rolle et al found increased overall adherence to the 2021 updated U.S. Preventive Services Task Force (USPSTF) lung cancer screening guidelin...

The ASCO Post

April 03, 2025

Youth Vaping: Comparable to Traditional Smoking, Study

Findings suggest that nicotine intake is similar among adolescents who vape and adolescents who smoke, highlighting critical implications for addiction.

Conexiant

April 03, 2025

Arizona oral preventive assistants bill becomes law

Dental assistants now have a pathway to become oral preventive assistants in Arizona after Gov. Katie Hobbs signed S.B. 1124 into law.  

ADA News

April 03, 2025

Neoadjuvant Durvalumab Plus Chemotherapy for High-Risk Upper-Tract Urothelial Carcinoma

In a French phase II trial (iNDUCT-GETUG V08) reported in the Journal of Clinical Oncology, Houédé et al found evidence of activity of neoadjuvant durvalumab plus chemotherapy in patients with high-ri...

The ASCO Post

April 03, 2025

Pulmonary Embolism in ESKD: New Data on Risk, Outcomes

Fewer than half of patients with end-stage kidney disease who survived pulmonary embolism filled an anticoagulation prescription, yet PE recurrence rates were similar between those who did and did not receive anticoagulation (4.2% vs. 2.8%; P = .11), according to a new study.

Conexiant

April 03, 2025

Study Reveals Psychiatric Sequelae Post-COVID-19

COVID-19 survivors showed a significantly higher risk of psychiatric disorders, according to a recent study.

Conexiant

April 03, 2025

Sitting Down With… The Past: Richard M. Linnehan

We dive into the archive of 2018 for insight and inspiration

The Pathologist